You are here:

  1. NICE
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Lipid disorders

Sebelipase alfa for treating Wolman disease

  • Highly specialised technologies guidance
  • Reference number: HST30
  • Published:  10 January 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Information about sebelipase alfa
  • 3 Committee discussion
  • 4 Implementation
  • 5 Evaluation committee members and NICE project team
  • Update information

Update information

Minor changes since publication

July 2024: We updated the commercial arrangement information in section 2.4 and section 3.15.

ISBN: 978-1-4731-5643-2


Previous page 5 Evaluation committee members and NICE project team